- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
4 result(s) found for: CYP2A6.
Displaying page 1 of 1.
EudraCT Number: 2009-016785-88 | Sponsor Protocol Number: AGO/2009/009 | Start Date*: 2010-01-06 |
Sponsor Name:University Hospital Ghent | ||
Full Title: Dexmedetomidine pharmacokinetics-pharmacodynamics in mechanically ventilated children with single-organ respiratory failure | ||
Medical condition: Patients admitted to the paediatric intensive care unit with single-organ respiratory failure | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023155-28 | Sponsor Protocol Number: AGO/2010/006 | Start Date*: 2011-02-14 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: Dexmedetomidine pharmacokinetics-pharmacodynamics in mechanically ventilated neonates with single-organ respiratory failure (NEODEX) | |||||||||||||
Medical condition: Patients admitted to the neonatal intensive care unit with single-organ respiratory failure | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000641-44 | Sponsor Protocol Number: TailorDose-II | Start Date*: 2017-04-28 | |||||||||||
Sponsor Name:Karolinska intitutet | |||||||||||||
Full Title: TailorDose®-II: Therapeutic dose monitoring of commonly used cytostatic drugs/regimes indicated for breast cancer | |||||||||||||
Medical condition: Newly diagnosed pre- or post-operative breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001852-38 | Sponsor Protocol Number: EFC10203 | Start Date*: 2007-12-21 | |||||||||||
Sponsor Name:sanofi-aventis recherche & developpement | |||||||||||||
Full Title: A Multicenter, Open-Label, Randomized Study Comparing the Efficacy and Safety of S-1 as a Single Agent at 30 mg/m2 BID versus 5-FU Bolus Infusion for the Treatment of Patients with Metastatic Panc... | |||||||||||||
Medical condition: Advanced Pancreatic Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Completed) SE (Completed) GR (Completed) DK (Prematurely Ended) AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
